Agivog M 0.3mg Tablet 10'S Tablet SR is classified as an antidiabetic medication that combines multiple ingredients to effectively manage type 2 diabetes mellitus in adult patients. This medicine aids in regulating blood glucose levels among individuals diagnosed with diabetes. It is important to take Agivog M 0.3mg Tablet 10'S Tablet SR with food to enhance its effectiveness. Consistency is key; therefore, it should be taken at the same time every day to ensure optimal outcomes. Your healthcare provider will determine the appropriate dosage based on your individual response and may adjust it as needed in accordance with your blood sugar monitoring. It is crucial to continue the treatment regimen, even when you feel well or your blood sugar appears stable. Discontinuing the medication without professional guidance could lead to elevated blood sugar levels, increasing the risk of serious complications such as kidney damage, vision impairment, nerve disorders, and potential limb loss. This medication should be regarded as part of a comprehensive management strategy that includes a nutritious diet, regular physical activity, and weight management as advised by your doctor. Your overall lifestyle plays a significant role in effectively controlling diabetes. While taking this medication, side effects may occur, including nausea, alterations in taste, reduced appetite, bloating, abdominal discomfort, diarrhea, and skin rashes. These effects are generally temporary and tend to resolve on their own. If they persist or cause concern, consult your healthcare provider for possible management strategies or treatments. It is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic impairment. Prior to initiation, inform your doctor of any history of heart disease, as this may affect the suitability of the medication. Pregnant or nursing individuals should also seek medical advice before starting this treatment, and regular monitoring of blood sugar levels, along with possible liver and blood cell count assessments, is recommended.